[Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Przeglad lekarski

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 25248240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study.

  2010cited by this paper
• Neoplastic hematopathology : experimental and clinical approaches

  2009cited by this paper
• How I monitor residual disease in chronic myeloid leukemia.

  2009cited by this paper
• molecule Beyond the increasing complexity of the immunomodulatory HLA-G

  2008influential reference
• Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.

  2008cited by this paper
• A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.

  2008influential reference
• Comparison of sensitivity of nested PCR and quantitative PCR in Bcr-Abl p210 transcript detection in chronic myelogenous leukemia

  2007cited by this paper
• An analysis of multiplex-PCR in the detection of BCR-ABL transcripts in hematological disorders

  2007cited by this paper
• Rational use of the EAC real-time quantitative PCR protocol in chronic myelogenous leukemia: report of three false-negative cases at diagnosis

  2006cited by this paper
• Chronic myeloid leukemia with an e13a3 BCR‐ABL fusion: Benign course responsive to imatinib with an RT‐PCR advisory

  2004cited by this paper
• Second case of CML with aberrant BCR‐ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence

  2004cited by this paper
• BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis

  2003cited by this paper
• Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects

  2003cited by this paper
• Comprehensive comparison of FISH, RT‐PCR, and RQ‐PCR for monitoring the BCR‐ABL gene after hematopoietic stem cell transplantation in CML

  2002cited by this paper
• Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients

  2002influential reference
• BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations

  2002cited by this paper
• E1A3 as a unique, naturally occurring BCR–ABL transcript in an indolent case of chronic myeloid leukaemia

  2001cited by this paper
• A novel BCR–ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia‐positive chronic myeloid leukaemia

  2000cited by this paper
• Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.

  1999cited by this paper
• Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

  1999cited by this paper
• A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene

  1998cited by this paper
• A novel BCR‐ABL fusion gene (e2/1a) in a patient with Philadelphia‐positive chronic myelogenous leukaemia and an aggressive clinical course

  1998cited by this paper
• A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. Is it really a distinct disease?

  1997cited by this paper
• Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia.

  1997cited by this paper
• BCR-ABL gene variants.

  1997cited by this paper
• New understanding of the pathogenesis of CML: a prototype of early neoplasia

  1997cited by this paper
• A novel acute lymphoid leukaemia type BCR/ABL transcript in chronic myelogenous leukaemia

  1997cited by this paper
• Detection of BCR-ABL in Hematological Malignancies by RT-PCR.

  1996cited by this paper
• Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

  1996cited by this paper
• A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

  1996cited by this paper
• An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders.

  1994cited by this paper
• Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

  1990cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties

  1985cited by this paper

• Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances

  2020cites this paper
• New rapid method to detect BCR-ABL fusion genes with multiplex RT-qPCR in one-tube at a time.

  2018cites this paper
• Heat‐Shock Protein 90 (Hsp90) as Anticancer Target for Drug Discovery: An Ample Computational Perspective

  2015cites this paper